MedMen Enterprises Inc.
MMNFQ
$0.00
$0.000.00%
OTC PK
03/25/2023 | 12/24/2022 | 09/24/2022 | 06/25/2022 | 03/26/2022 | |
---|---|---|---|---|---|
Revenue | -17.45% | -9.84% | 0.18% | 6.48% | 15.38% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -17.45% | -9.84% | 0.18% | 6.48% | 15.38% |
Cost of Revenue | -20.24% | -16.64% | -7.33% | -0.61% | 2.88% |
Gross Profit | -14.47% | -1.89% | 8.99% | 14.82% | 32.50% |
SG&A Expenses | -38.07% | -28.98% | -11.67% | 4.15% | 3.33% |
Depreciation & Amortization | -25.71% | -20.29% | -7.97% | -8.55% | -37.54% |
Other Operating Expenses | 3.98% | -1,538.45% | -9,042.05% | -2,082.01% | -114.97% |
Total Operating Expenses | -31.12% | -27.67% | -12.87% | -1.37% | -3.97% |
Operating Income | 58.04% | 59.03% | 36.01% | 15.10% | 27.81% |
Income Before Tax | -90.96% | -34.38% | -20.02% | -38.80% | 76.49% |
Income Tax Expenses | -308.98% | 15.19% | -396.36% | -639.51% | 36.35% |
Earnings from Continuing Operations | -47.45% | -45.33% | 6.72% | -28.79% | 74.17% |
Earnings from Discontinued Operations | 108.52% | 94.64% | 71.02% | -52.61% | -90.74% |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -4.24% | 3.72% | -62.10% | -53.05% | -92.38% |
Net Income | 5.81% | -4.72% | 13.87% | -57.22% | 40.98% |
EBIT | 58.04% | 59.03% | 36.01% | 15.10% | 27.81% |
EBITDA | 71.36% | 74.67% | 56.50% | 26.12% | 30.58% |
EPS Basic | 33.33% | 34.00% | 55.85% | 32.06% | 57.88% |
Normalized Basic EPS | 56.28% | 78.53% | 72.90% | 64.36% | -165.52% |
EPS Diluted | 36.69% | 33.19% | 52.49% | 28.76% | 55.65% |
Normalized Diluted EPS | 56.28% | 78.53% | 72.90% | 64.36% | -165.52% |
Average Basic Shares Outstanding | 29.69% | 51.11% | 88.13% | 117.25% | 72.53% |
Average Diluted Shares Outstanding | 29.69% | 51.11% | 88.13% | 117.25% | 72.53% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |